Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment - A national drug abuse treatment clinical trials network study

被引:249
|
作者
Peirce, JM
Petry, NM
Stitzer, ML
Blaine, J
Kellogg, S
Satterfield, F
Schwartz, M
Krasnansky, J
Pencer, E
Silva-Vazquez, L
Kirby, KC
Roger-Malvestuto, C
Roll, JM
Cohen, A
Copersino, ML
Kolodner, K
机构
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[2] Univ Connecticut, Sch Med, New Haven, CT USA
[3] Biopharmaceut Res Consultants Inc, Ann Arbor, MI USA
[4] NYU, New York, NY USA
[5] Rockefeller Univ, New York, NY 10021 USA
[6] Univ Penn, Philadelphia, PA 19104 USA
[7] Treatment Res Inst, Philadelphia, PA USA
[8] Washington State Univ, Washington Inst Mental Illness Res & Training, Spokane, WA USA
[9] Univ Calif Los Angeles, Los Angeles, CA USA
[10] NIDA, Intramural Res Program, Baltimore, MD USA
关键词
D O I
10.1001/archpsyc.63.2.201
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Contingency management interventions that provide tangible incentives based on objective indicators of drug abstinence have improved treatment outcomes of substance abusers, but have not been widely implemented in community drug abuse treatment settings. Objective: To compare outcomes achieved when a lower-cost prize-based contingency management treatment is added to usual care in community methadone hydrochloride maintenance treatment settings. Design: Random assignment to usual care with (n = 198) or without (n = 190) abstinence incentives during a 12-week trial. Setting: Six community-based methadone maintenance drug abuse treatment clinics in locations across the United States. Participants: Three hundred eighty-eight stimulant-abusing patients enrolled in methadone maintenance programs for at least 1 month and no more than 3 years. Intervention: Participants submitting stimulant- and alcohol-negative samples earned draws for a chance to win prizes; the number of draws earned increased with continuous abstinence time. Main Outcome Measures: Total number of stimulant- and alcohol-negative samples provided, percentage of stimulant- and alcohol-negative samples provided, longest duration of abstinence, retention, and counseling attendance. Results: Submission of stimulant- and alcohol-negative samples was twice as likely for incentive as for usual care group participants (odds ratio, 1.98; 95% confidence interval, 1.42-2.77). Achieving 4 or more, 8 or more, and 12 weeks of continuous abstinence was approximately 3, 9, and 11 times more likely, respectively, for incentive vs usual care participants. Groups did not differ on study retention or counseling attendance. The average cost of prizes was $120 per participant. Conclusion: An abstinence incentive approach that paid $120 in prizes per participant effectively increased stimulant abstinence in community-based methadone maintenance treatment clinics.
引用
收藏
页码:201 / 208
页数:8
相关论文
共 50 条
  • [41] Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Network Trial
    Yih-Ing Hser
    Allison J. Ober
    Alex R. Dopp
    Chunqing Lin
    Katie P. Osterhage
    Sarah E. Clingan
    Larissa J. Mooney
    Megan E. Curtis
    Lisa A. Marsch
    Bethany McLeman
    Emily Hichborn
    Laurie S. Lester
    Laura-Mae Baldwin
    Yanping Liu
    Petra Jacobs
    Andrew J. Saxon
    Addiction Science & Clinical Practice, 16
  • [42] Technology transfer for the implementation of a clinical trials network on drug abuse and mental health treatment in Mexico
    Horigian, Viviana E.
    Marin-Navarrete, Rodrigo A.
    Verdeja, Rosa E.
    Alonso, Elizabeth
    Perez, Maria A.
    Fernandez-Mondragon, Jose
    Berlanga, Carlos
    Elena Medina-Mora, Maria
    Szapocznik, Jose
    REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2015, 38 (03): : 233 - 242
  • [43] Using a latent variable approach to inform gender and racial/ethnic differences in cocaine dependence: A National Drug Abuse Treatment Clinical Trials Network study
    Wu, Li-Tzy
    Pan, Jeng-Jong
    Blazer, Dan G.
    Tai, Betty
    Stitzer, Maxine L.
    Woody, George E.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2010, 38 (04) : S70 - S79
  • [44] Use of single IRBs for multi-site studies: A case report and commentary from a National Drug Abuse Treatment Clinical Trials Network study
    Nichols, Ceilidh
    Kunkel, Lynn E.
    Baker, Robin
    Jelstrom, Eve
    Addis, Megan
    Hoffman, Kim A.
    McCarty, Dennis
    Korthuis, P. Todd
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2019, 14
  • [45] Sociodemographic and Substance Use Disorder Determinants of HIV Sexual Risk Behavior in Men and Women in Outpatient Drug Treatment in the NIDA National Drug Abuse Treatment Clinical Trials Network
    Kidd, Jeremy D.
    Tross, Susan
    Pavlicova, Martina
    Hu, Mei-Chen
    Campbell, Aimee N. C.
    Nunes, Edward V.
    SUBSTANCE USE & MISUSE, 2017, 52 (07) : 858 - 865
  • [46] Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: The National Drug Abuse Treatment Clinical Trials Network
    Brown, Lawrence S., Jr.
    Kritz, Steven Allan
    Goldsmith, R. Jeffrey
    Bini, Edmund J.
    Rotrosen, John
    Baker, Sherryl
    Robinson, Jim
    McAuliffe, Patrick
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2006, 30 (04) : 315 - 321
  • [47] Mortality Rates Among Substance Use Disorder Participants in Clinical Trials: Pooled Analysis of Twenty-Two Clinical Trials Within the National Drug Abuse Treatment Clinical Trials Network
    Lindblad, Robert
    Hu, Lian
    Oden, Neal
    Wakim, Paul
    Rosa, Carmen
    VanVeldhuisen, Paul
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2016, 70 : 73 - 80
  • [48] A SYSTEMATIC SCOPING REVIEW OF AMERICAN INDIAN, ALASKA NATIVE, AND NATIVE HAWAIIAN PARTICIPANTS IN THE NATIONAL DRUG ABUSE TREATMENT CLINICAL TRIALS NETWORK
    Crouch, M. C.
    Haeny, A. M.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 46 : 118A - 118A
  • [49] Increasing collaboration on substance use disorder research with primary care practices through the National Drug Abuse Treatment Clinical Trials Network
    Baldwin, Laura-Mae
    Mollis, Brenda
    Witwer, Elizabeth
    Halladay, Jacqueline R.
    Ludden, Tom
    Elder, Nancy
    Tapp, Hazel
    Donahue, Katrina E.
    Johnson, Deborah
    Mottus, Kathleen
    Olson, Ardis L.
    Waddell, Elizabeth Needham
    Dolor, Rowena J.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2020, 112 : 34 - 40
  • [50] Retention in the National Institute on Drug Abuse Clinical Trials Network Women and Trauma Study: Implications for Posttrial Implementation
    Pinto, Rogerio M.
    Campbell, Aimee N. C.
    Hien, Denise A.
    Yu, Gary
    Gorroochurn, Prakash
    AMERICAN JOURNAL OF ORTHOPSYCHIATRY, 2011, 81 (02) : 211 - 217